Roche’s Xolar reduces severe food allergy reactions in study
Xolar, an asthma drug marketed 20 years ago by Roche and Novartis significantly reduced allergic reactions in people with multiple severe food allergies in a late-stage study, researchers reported Sunday at a medical meeting.
POPULAR POSTS
IEA warns ‘electricity era’ will come after fossil fuels peak
October 17, 2024
Easter Island fights global plastic waste vortex
October 17, 2024
Egypt opens more galleries at its antiquities museum
October 17, 2024
LIVE STREAM